Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −905,384−100.0% | Sold out | Holders |
| Q3 2024 | 905,384 | $13.9M | 1.7% | 00.0% | Unchanged | Holders |
| Q2 2024 | 905,384 | $14.7M | 4.2% | +64,931+7.7% | Added | Holders |
| Q1 2024 | 840,453 | $15.5M | 4.0% | +70,800+9.2% | Added | Holders |
| Q4 2023 | 769,653 | $24.1M | 8.3% | +213,100+38.3% | Added | Holders |
| Q3 2023 | 556,553 | $11.6M | 5.8% | −290,400−34.3% | Reduced | Holders |
| Q2 2023 | 846,953 | $20.3M | 7.0% | −69,400−7.6% | Reduced | Holders |
| Q1 2023 | 916,353 | $17.2M | 6.6% | −260,477−22.1% | Reduced | Holders |
| Q4 2022 | 1,176,830 | $18.7M | 6.1% | +65,800+5.9% | Added | Holders |
| Q3 2022 | 1,111,030 | $18.2M | 6.0% | +403,830+57.1% | Added | Holders |
| Q2 2022 | 707,200 | $9.96M | 3.4% | +707,200 | New | Holders |